Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 61 to 61 of 61 entries
Sorted by: Best Match Show Resources per page
Nanoparticles use for Delivering Ursolic Acid in Cancer Therapy: A Scoping Review.

Frontiers in pharmacology

Miatmoko A, Mianing EA, Sari R, Hendradi E.
PMID: 35002719
Front Pharmacol. 2021 Dec 24;12:787226. doi: 10.3389/fphar.2021.787226. eCollection 2021.

Ursolic acid is a natural pentacyclic triterpenoid that exerts a potent anticancer effect. Furthermore, it is classified as a BCS class IV compound possessing low permeability and water solubility, consequently demonstrating limited bioavailability in addition to low therapeutic effectiveness....

Cite
Miatmoko A, Mianing EA, Sari R, et al. Nanoparticles use for Delivering Ursolic Acid in Cancer Therapy: A Scoping Review. Front Pharmacol. 2021;12:787226doi: 10.3389/fphar.2021.787226.
Miatmoko, A., Mianing, E. A., Sari, R., & Hendradi, E. (2021). Nanoparticles use for Delivering Ursolic Acid in Cancer Therapy: A Scoping Review. Frontiers in pharmacology, 12787226. https://doi.org/10.3389/fphar.2021.787226
Miatmoko, Andang, et al. "Nanoparticles use for Delivering Ursolic Acid in Cancer Therapy: A Scoping Review." Frontiers in pharmacology vol. 12 (2021): 787226. doi: https://doi.org/10.3389/fphar.2021.787226
Miatmoko A, Mianing EA, Sari R, Hendradi E. Nanoparticles use for Delivering Ursolic Acid in Cancer Therapy: A Scoping Review. Front Pharmacol. 2021 Dec 24;12:787226. doi: 10.3389/fphar.2021.787226. eCollection 2021. PMID: 35002719; PMCID: PMC8740088.
Copy Download .nbib Format: NLM
Showing 61 to 61 of 61 entries